ATP5F1E

Chr 20AR

ATP synthase F1 subunit epsilon

Also known as: ATP5E, ATPE, MC5DN3

ATP5F1E encodes the epsilon subunit of mitochondrial ATP synthase, which catalyzes ATP synthesis utilizing the electrochemical proton gradient across the inner mitochondrial membrane during oxidative phosphorylation. Biallelic mutations cause mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, inherited in an autosomal recessive pattern. The pathogenic mechanism appears to involve gain-of-function effects.

Summary from RefSeq, OMIM, UniProt, Mechanism
Research Assistant →

Primary Disease Associations & Inheritance

Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3MIM #614053
AR
0
Active trials
3
Pubs (1 yr)
19
P/LP submissions
5%
P/LP missense
1.79
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryATP5F1E
Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
19 unique Pathogenic / Likely Pathogenic· 18 VUS of 60 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.79LOEUF
pLI 0.009
Z-score 0.26
OE 0.85 (0.381.79)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.17Z-score
OE missense 1.10 (0.811.50)
28 obs / 25.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.85 (0.381.79)
00.351.4
Missense OE1.10 (0.811.50)
00.61.4
Synonymous OE1.18
01.21.6
LoF obs/exp: 3 / 3.5Missense obs/exp: 28 / 25.5Syn Z: -0.42
DN
0.6745th %ile
GOF
0.75top 25%
LOF
0.3940th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

60 submitted variants in ClinVar

Classification Summary

Pathogenic16
Likely Pathogenic3
VUS18
Likely Benign14
Benign9
16
Pathogenic
3
Likely Pathogenic
18
VUS
14
Likely Benign
9
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
15
0
16
Likely Pathogenic
0
0
3
0
3
VUS
0
10
8
0
18
Likely Benign
0
1
6
7
14
Benign
0
0
9
0
9
Total01241760

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ATP5F1E · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found